Breaking News Instant updates and real-time market news.

ADSK

Autodesk

$191.41 /

-2.575 (-1.33%)

06:55
05/23/22
05/23
06:55
05/23/22
06:55

Deutsche Bank downgrades Autodesk on risk to consensus estimates

Deutsche Bank analyst Bhavin Shah downgraded Autodesk to Hold from Buy with a price target of $225, down from $275. Conversations with platinum partners indicate "mixed" Q1 results and downside to fiscal 2023 estimates from changing demand, potentially lower adoption of multi-year contracts, currency and Russia, Shah tells investors in a research note. The analyst also sees downside to fiscal 2024 billings and cash flow estimates saying the consensus is mismodelling the impact from Autodesk's migration away from three-year upfront contracts. Shah expects the company to guide down fiscal 2023.

  • 26

    May

  • 16

    Jun

OTHER BREAKING NEWS FROM THE FLY

Upgrade
PGS ASA upgraded to Buy from Hold at Pareto » 05:16
07/05/22
07/05
05:16
07/05/22
05:16
PGEJF

PGS ASA

/

+

Pareto analyst Bard Rosef…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Cognizant selected as strategic technology provider by NICL » 05:16
07/05/22
07/05
05:16
07/05/22
05:16
CTSH

Cognizant

$68.03 /

+0.54 (+0.80%)

Cognizant announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$68.03 /

+0.54 (+0.80%)

CTSH Cognizant
$68.03 /

+0.54 (+0.80%)

05/09/22 Cowen
Cognizant price target lowered to $95 from $98 at Cowen
05/05/22 Citi
Cognizant price target lowered to $88 from $95 at Citi
02/07/22 Barclays
Cognizant price target raised to $85 from $78 at Barclays
02/03/22 BMO Capital
Cognizant price target raised to $100 from $92 at BMO Capital
CTSH Cognizant
$68.03 /

+0.54 (+0.80%)

CTSH Cognizant
$68.03 /

+0.54 (+0.80%)

Recommendations
Bottom in med tech shares is 'getting close,' says Piper Sandler » 05:14
07/05/22
07/05
05:14
07/05/22
05:14
BSX

Boston Scientific

$37.99 /

+0.73 (+1.96%)

, HSIC

Henry Schein

$77.08 /

+0.35 (+0.46%)

, ATRC

AtriCure

$41.03 /

+0.22 (+0.54%)

, AXNX

Axonics

$57.99 /

+1.44 (+2.55%)

, LIVN

LivaNova

$63.33 /

+1.03 (+1.65%)

, PDCO

Patterson Companies

$30.60 /

+0.39 (+1.29%)

, TNDM

TNDM

/

+

Piper Sandler analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BSX Boston Scientific
$37.99 /

+0.73 (+1.96%)

HSIC Henry Schein
$77.08 /

+0.35 (+0.46%)

ATRC AtriCure
$41.03 /

+0.22 (+0.54%)

AXNX Axonics
$57.99 /

+1.44 (+2.55%)

LIVN LivaNova
$63.33 /

+1.03 (+1.65%)

PDCO Patterson Companies
$30.60 /

+0.39 (+1.29%)

TNDM TNDM
/

+

BSX Boston Scientific
$37.99 /

+0.73 (+1.96%)

06/29/22 Canaccord
Boston Scientific price target lowered to $43 from $51 at Canaccord
06/24/22 BTIG
Boston Scientific price target lowered to $45 from $52 at BTIG
06/15/22 Piper Sandler
Piper Sandler overall constructive on Boston Scientific's MedSurg business deal
05/27/22 Needham
Needham upgrades Boston Scientific to Buy, sees stock as potential M&A target
HSIC Henry Schein
$77.08 /

+0.35 (+0.46%)

06/17/22 Stifel
Henry Schein price target lowered to $80 from $90 at Stifel
06/14/22 Baird
Baird downgrades Henry Schein to Neutral after dental survey points to slowing
06/14/22 Baird
Henry Schein downgraded to Neutral from Outperform at Baird
05/12/22 Credit Suisse
Henry Schein assumed with an Outperform at Credit Suisse
ATRC AtriCure
$41.03 /

+0.22 (+0.54%)

06/28/22 Needham
AtriCure price target lowered to $55 from $67 at Needham
06/24/22 BTIG
AtriCure price target lowered to $75 from $94 at BTIG
05/04/22 Needham
AtriCure price target lowered to $67 from $79 at Needham
04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
AXNX Axonics
$57.99 /

+1.44 (+2.55%)

05/06/22 Piper Sandler
Axonics price target raised to $77 from $75 at Piper Sandler
04/05/22 Wolfe Research
Axonics initiated with an Outperform at Wolfe Research
03/14/22 Piper Sandler
Axonics remains 'high-conviction idea' at Piper Sandler
03/07/22 Piper Sandler
Timing of Axonics' SNM solutions approval in line with expectations, says Piper
LIVN LivaNova
$63.33 /

+1.03 (+1.65%)

05/05/22 Piper Sandler
LivaNova price target lowered to $99 from $104 at Piper Sandler
04/05/22 Wolfe Research
LivaNova initiated with an Outperform at Wolfe Research
03/14/22 Piper Sandler
LivaNova study milestone should be well received, says Piper Sandler
02/24/22 UBS
LivaNova upgraded to Buy from Neutral at UBS
PDCO Patterson Companies
$30.60 /

+0.39 (+1.29%)

06/29/22 Piper Sandler
Patterson Companies price target raised to $42 from $41 at Piper Sandler
05/12/22 Credit Suisse
Patterson Companies assumed with an Outperform at Credit Suisse
03/02/22 Piper Sandler
Piper says Patterson results should be 'more than enough' to support move higher
02/01/22 Baird
Dental survey results for January 'aren't pretty,' says Baird
TNDM TNDM
/

+

06/01/22 Lake Street
Abbott approval for Libre 3 'a huge positive' for Tandem, says Lake Street
05/31/22 Piper Sandler
Abbott approval bodes well for DexCom, Tandem, says Piper Sandler
05/31/22 Wells Fargo
Wells Fargo glad DexCom, Insulet merger is not happening
05/25/22 Lake Street
Lake Street says diabetes industry consolidation unlikely to hurt Tandem
BSX Boston Scientific
$37.99 /

+0.73 (+1.96%)

HSIC Henry Schein
$77.08 /

+0.35 (+0.46%)

ATRC AtriCure
$41.03 /

+0.22 (+0.54%)

AXNX Axonics
$57.99 /

+1.44 (+2.55%)

LIVN LivaNova
$63.33 /

+1.03 (+1.65%)

PDCO Patterson Companies
$30.60 /

+0.39 (+1.29%)

TNDM TNDM
/

+

  • 04
    Aug
BSX Boston Scientific
$37.99 /

+0.73 (+1.96%)

HSIC Henry Schein
$77.08 /

+0.35 (+0.46%)

PDCO Patterson Companies
$30.60 /

+0.39 (+1.29%)

BSX Boston Scientific
$37.99 /

+0.73 (+1.96%)

HSIC Henry Schein
$77.08 /

+0.35 (+0.46%)

Hot Stocks
AST SpaceMobile to sell majority ownership stake in NanoAvionics for $68M » 05:13
07/05/22
07/05
05:13
07/05/22
05:13
ASTS

AST SpaceMobile

$6.33 /

+0.065 (+1.04%)

AST SpaceMobile announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASTS AST SpaceMobile
$6.33 /

+0.065 (+1.04%)

ASTS AST SpaceMobile
$6.33 /

+0.065 (+1.04%)

05/24/22 Deutsche Bank
AST SpaceMobile price target lowered to $31 from $32 at Deutsche Bank
04/01/22 Deutsche Bank
AST SpaceMobile price target lowered to $32 from $35 at Deutsche Bank
07/12/21 Barclays
AST SpaceMobile initiated with an Overweight at Barclays
ASTS AST SpaceMobile
$6.33 /

+0.065 (+1.04%)

ASTS AST SpaceMobile
$6.33 /

+0.065 (+1.04%)

Hot Stocks
Elbit Systems awarded $80M contract to supply DIRCM, EW systems » 05:12
07/05/22
07/05
05:12
07/05/22
05:12
ESLT

Elbit Systems

$227.66 /

-3.21 (-1.39%)

Elbit Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESLT Elbit Systems
$227.66 /

-3.21 (-1.39%)

ESLT Elbit Systems
$227.66 /

-3.21 (-1.39%)

ESLT Elbit Systems
$227.66 /

-3.21 (-1.39%)

Hot Stocks
InterDigital signs multi-year royalty bearing license with Zebra Technologies » 05:09
07/05/22
07/05
05:09
07/05/22
05:09
IDCC

InterDigital

$60.60 /

-0.82 (-1.34%)

, ZBRA

Zebra Technologies

$299.20 /

+6.75 (+2.31%)

InterDigital (IDCC)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IDCC InterDigital
$60.60 /

-0.82 (-1.34%)

ZBRA Zebra Technologies
$299.20 /

+6.75 (+2.31%)

IDCC InterDigital
$60.60 /

-0.82 (-1.34%)

08/03/21 Roth Capital
Court ruling sets tone for unlicensed Chinese OEMs in Europe, says Roth Capital
ZBRA Zebra Technologies
$299.20 /

+6.75 (+2.31%)

05/23/22 Morgan Stanley
Zebra Technologies assumed at Equal Weight from Underweight at Morgan Stanley
05/04/22 Needham
Zebra Technologies price target lowered to $500 from $535 at Needham
05/04/22 Baird
Zebra Technologies price target lowered to $440 from $550 at Baird
04/12/22 Morgan Stanley
Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious
IDCC InterDigital
$60.60 /

-0.82 (-1.34%)

ZBRA Zebra Technologies
$299.20 /

+6.75 (+2.31%)

IDCC InterDigital
$60.60 /

-0.82 (-1.34%)

ZBRA Zebra Technologies
$299.20 /

+6.75 (+2.31%)

ZBRA Zebra Technologies
$299.20 /

+6.75 (+2.31%)

Hot Stocks
Nokia wins five-year 5G deal with Ice » 05:07
07/05/22
07/05
05:07
07/05/22
05:07
NOK

Nokia

$4.66 /

+0.04 (+0.87%)

Nokia announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOK Nokia
$4.66 /

+0.04 (+0.87%)

NOK Nokia
$4.66 /

+0.04 (+0.87%)

06/14/22 Citi
Nokia upgraded to Buy from Neutral at Citi
05/18/22 Deutsche Bank
Nokia price target lowered to EUR 6 from EUR 6.50 at Deutsche Bank
05/13/22 AlphaValue/Baader
Nokia upgraded to Buy from Add at AlphaValue/Baader
04/29/22 UBS
Nokia price target lowered to EUR 5.80 from EUR 6.20 at UBS
NOK Nokia
$4.66 /

+0.04 (+0.87%)

NOK Nokia
$4.66 /

+0.04 (+0.87%)

NOK Nokia
$4.66 /

+0.04 (+0.87%)

NOK Nokia
$4.66 /

+0.04 (+0.87%)

Recommendations
Wynn Resorts price target lowered to $87.50 from $92 at Citi » 05:06
07/05/22
07/05
05:06
07/05/22
05:06
WYNN

Wynn Resorts

$58.15 /

+1.205 (+2.12%)

Citi analyst George Choi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WYNN Wynn Resorts
$58.15 /

+1.205 (+2.12%)

WYNN Wynn Resorts
$58.15 /

+1.205 (+2.12%)

06/29/22 Barclays
Barclays initiates gaming sector, says Caesars best positioned
06/28/22 Barclays
Wynn Resorts initiated with an Equal Weight at Barclays
05/11/22 Deutsche Bank
Wynn Resorts price target lowered to $92 from $123 at Deutsche Bank
05/11/22 Wells Fargo
Wynn Resorts price target lowered to $79 from $97 at Wells Fargo
WYNN Wynn Resorts
$58.15 /

+1.205 (+2.12%)

WYNN Wynn Resorts
$58.15 /

+1.205 (+2.12%)

WYNN Wynn Resorts
$58.15 /

+1.205 (+2.12%)

WYNN Wynn Resorts
$58.15 /

+1.205 (+2.12%)

Recommendations
MGM Resorts price target lowered to $56 from $59 at Citi » 05:06
07/05/22
07/05
05:06
07/05/22
05:06
MGM

MGM Resorts

$30.00 /

+1.05 (+3.63%)

Citi analyst George Choi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGM MGM Resorts
$30.00 /

+1.05 (+3.63%)

MGM MGM Resorts
$30.00 /

+1.05 (+3.63%)

06/28/22 JMP Securities
MGM Resorts initiated with an Outperform at JMP Securities
05/20/22 Deutsche Bank
MGM Resorts price target lowered to $48 from $52 at Deutsche Bank
05/11/22 Oppenheimer
IAC price target lowered to $135 from $155 at Oppenheimer
05/03/22 CBRE
MGM Resorts 'primed for firing on all cylinders,' says CBRE
MGM MGM Resorts
$30.00 /

+1.05 (+3.63%)

MGM MGM Resorts
$30.00 /

+1.05 (+3.63%)

MGM MGM Resorts
$30.00 /

+1.05 (+3.63%)

MGM MGM Resorts
$30.00 /

+1.05 (+3.63%)

Recommendations
Melco Resorts price target lowered to $11 from $12.50 at Citi » 05:06
07/05/22
07/05
05:06
07/05/22
05:06
MLCO

Melco Resorts & Entertainment

$6.01 /

+0.255 (+4.43%)

Citi analyst George Choi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MLCO Melco Resorts & Entertainment
$6.01 /

+0.255 (+4.43%)

MLCO Melco Resorts & Entertainment
$6.01 /

+0.255 (+4.43%)

05/09/22 CICC
Melco Resorts downgraded to Market Perform from Outperform at CICC
05/06/22 CLSA
Melco Resorts & Entertainment upgraded to Buy from Outperform at CLSA
04/12/22 Citi
Citi opens '30-day positive Catalyst Watches' on Melco, Galaxy
01/18/22 Citi
Melco Resorts & Entertainment price target raised to $15 from $13.50 at Citi
MLCO Melco Resorts & Entertainment
$6.01 /

+0.255 (+4.43%)

MLCO Melco Resorts & Entertainment
$6.01 /

+0.255 (+4.43%)

MLCO Melco Resorts & Entertainment
$6.01 /

+0.255 (+4.43%)

MLCO Melco Resorts & Entertainment
$6.01 /

+0.255 (+4.43%)

Recommendations
Las Vegas Sands price target lowered to $56 from $57 at Citi » 05:05
07/05/22
07/05
05:05
07/05/22
05:05
LVS

Las Vegas Sands

$35.28 /

+1.67 (+4.97%)

Citi analyst George Choi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVS Las Vegas Sands
$35.28 /

+1.67 (+4.97%)

LVS Las Vegas Sands
$35.28 /

+1.67 (+4.97%)

06/29/22 Barclays
Barclays initiates gaming sector, says Caesars best positioned
06/28/22 Barclays
Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names
06/28/22 Barclays
Las Vegas Sands initiated with an Overweight at Barclays
04/28/22 Stifel
Las Vegas Sands price target lowered to $46 from $56 at Stifel
LVS Las Vegas Sands
$35.28 /

+1.67 (+4.97%)

LVS Las Vegas Sands
$35.28 /

+1.67 (+4.97%)

LVS Las Vegas Sands
$35.28 /

+1.67 (+4.97%)

LVS Las Vegas Sands
$35.28 /

+1.67 (+4.97%)

Hot Stocks
Natuzzi shareholders approve new stock option plan » 05:05
07/05/22
07/05
05:05
07/05/22
05:05
NTZ

Natuzzi

$7.92 /

+0.4 (+5.32%)

Natuzzi announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTZ Natuzzi
$7.92 /

+0.4 (+5.32%)

NTZ Natuzzi
$7.92 /

+0.4 (+5.32%)

Recommendations
Citi opens '90-day positive Catalyst Watch' on MakeMyTrip » 05:01
07/05/22
07/05
05:01
07/05/22
05:01
MMYT

MakeMyTrip

$25.90 /

+0.2 (+0.78%)

Citi analyst Vijit Jain…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMYT MakeMyTrip
$25.90 /

+0.2 (+0.78%)

MMYT MakeMyTrip
$25.90 /

+0.2 (+0.78%)

06/13/22 UBS
MakeMyTrip upgraded to Buy from Sell at UBS (earlier)
05/26/22 Citi
MakeMyTrip price target raised to $43 from $42 at Citi
02/24/22 Morgan Stanley
MakeMyTrip initiated with an Equal Weight at Morgan Stanley
10/27/21 Citi
MakeMyTrip price target raised to $42 from $38 at Citi
MMYT MakeMyTrip
$25.90 /

+0.2 (+0.78%)

MMYT MakeMyTrip
$25.90 /

+0.2 (+0.78%)

Initiation
Greentown Management initiated with a Buy at Citi » 04:58
07/05/22
07/05
04:58
07/05/22
04:58
GRMHF

Greentown Management

/

+

Citi analyst Cindy Li…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 » 04:55
07/05/22
07/05
04:55
07/05/22
04:55
EHAB

Enhabit

$22.50 /

-0.5 (-2.17%)

, LYLT

Loyalty Ventures

$3.53 /

-0.075 (-2.08%)

, EHC

Encompass Health

$46.53 /

-9.485 (-16.93%)

Encompass Health (EHC) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EHAB Enhabit
$22.50 /

-0.5 (-2.17%)

LYLT Loyalty Ventures
$3.53 /

-0.075 (-2.08%)

EHC Encompass Health
$46.53 /

-9.485 (-16.93%)

EHAB Enhabit
$22.50 /

-0.5 (-2.17%)

LYLT Loyalty Ventures
$3.53 /

-0.075 (-2.08%)

06/08/22 Needham
Loyalty Ventures' Sobeys new 'hurts,' but pullback looks overdone, says Needham
06/03/22 Needham
Needham starts Loyalty Ventures at Buy on 'attractive' loyalty tech, valuation
06/03/22 Needham
Loyalty Ventures initiated with a Buy at Needham
02/25/22 Morgan Stanley
Loyalty Ventures initiated with an Equal Weight at Morgan Stanley
EHC Encompass Health
$46.53 /

-9.485 (-16.93%)

06/21/22 Truist
Encompass Health price target lowered to $75 from $85 at Truist
06/21/22 Stephens
Encompass Health price target lowered to $74 from $78 at Stephens
06/17/22 Raymond James
Encompass Health price target lowered to $70 from $85 at Raymond James
06/08/22 RBC Capital
Encompass Health price target lowered to $82 from $85 at RBC Capital
EHC Encompass Health
$46.53 /

-9.485 (-16.93%)

EHC Encompass Health
$46.53 /

-9.485 (-16.93%)

EHAB Enhabit
$22.50 /

-0.5 (-2.17%)

EHC Encompass Health
$46.53 /

-9.485 (-16.93%)

LYLT Loyalty Ventures
$3.53 /

-0.075 (-2.08%)

EHC Encompass Health
$46.53 /

-9.485 (-16.93%)

Hot Stocks
Sun Country Airlines to replace Neenah in S&P 600 at open on 7/5 » 04:55
07/05/22
07/05
04:55
07/05/22
04:55
SNCY

Sun Country Airlines

$18.38 /

+0.085 (+0.46%)

, NP

Neenah

$33.77 /

-0.37 (-1.08%)

, SWM

Schweitzer-Mauduit

/

+

SchweitzerMauduit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNCY Sun Country Airlines
$18.38 /

+0.085 (+0.46%)

NP Neenah
$33.77 /

-0.37 (-1.08%)

SWM Schweitzer-Mauduit
/

+

SNCY Sun Country Airlines
$18.38 /

+0.085 (+0.46%)

06/27/22 Evercore ISI
Sun Country Airlines price target lowered to $30 from $45 at Evercore ISI
04/07/22 Barclays
Sun Country Airlines price target lowered to $32 from $35 at Barclays
02/15/22 Wolfe Research
Wolfe upgrades three, downgrades one in U.S. Airlines as new analyst takes over
02/08/22 Deutsche Bank
Sun Country Airlines price target lowered to $37 from $46 at Deutsche Bank
NP Neenah
$33.77 /

-0.37 (-1.08%)

07/06/21 Sidoti
Neenah upgraded to Buy from Neutral at Sidoti
SWM Schweitzer-Mauduit
/

+

SNCY Sun Country Airlines
$18.38 /

+0.085 (+0.46%)

NP Neenah
$33.77 /

-0.37 (-1.08%)

SWM Schweitzer-Mauduit
/

+

  • 15
    Oct
SNCY Sun Country Airlines
$18.38 /

+0.085 (+0.46%)

Conference/Events
Jefferies technology analyst to hold an analyst/industry conference call » 04:55
07/05/22
07/05
04:55
07/05/22
04:55
HUBS

HubSpot

$313.62 /

+12.78 (+4.25%)

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUBS HubSpot
$313.62 /

+12.78 (+4.25%)

HUBS HubSpot
$313.62 /

+12.78 (+4.25%)

06/09/22 Scotiabank
Scotiabank starts 'must-own' HubSpot at Outperform with $550 price target
06/08/22 Scotiabank
HubSpot initiated with an Outperform at Scotiabank
05/23/22 Jefferies
HubSpot price target lowered to $450 from $500 at Jefferies
05/06/22 BMO Capital
HubSpot price target lowered to $405 from $485 at BMO Capital
HUBS HubSpot
$313.62 /

+12.78 (+4.25%)

HUBS HubSpot
$313.62 /

+12.78 (+4.25%)

Hot Stocks
Stride to replace Omnicell in S&P 600 at open on 7/5  04:55
07/05/22
07/05
04:55
07/05/22
04:55
LRN

Stride

$41.36 /

+0.425 (+1.04%)

, OMCL

Omnicell

$115.30 /

+1.62 (+1.43%)

 
ShowHide Related Items >><<
LRN Stride
$41.36 /

+0.425 (+1.04%)

OMCL Omnicell
$115.30 /

+1.62 (+1.43%)

LRN Stride
$41.36 /

+0.425 (+1.04%)

04/21/22 Citi
Citi remains buyer of Stride with $65 price target
04/20/22 Barrington
Stride price target raised to $50 from $45 at Barrington
09/14/21
Fly Intel: Top five analyst initiations
09/14/21 Citi
Stride initiated with a Buy at Citi
OMCL Omnicell
$115.30 /

+1.62 (+1.43%)

06/16/22 Wells Fargo
Samsung procurement order halt 'positive' for Omnicell, says Wells Fargo
05/03/22 Wells Fargo
Omnicell price target lowered to $158 from $188 at Wells Fargo
05/02/22 Piper Sandler
Omnicell price target lowered to $162 from $181 at Piper Sandler
02/16/22 Wells Fargo
Omnicell price target lowered to $188 from $203 at Wells Fargo
LRN Stride
$41.36 /

+0.425 (+1.04%)

OMCL Omnicell
$115.30 /

+1.62 (+1.43%)

LRN Stride
$41.36 /

+0.425 (+1.04%)

OMCL Omnicell
$115.30 /

+1.62 (+1.43%)

LRN Stride
$41.36 /

+0.425 (+1.04%)

Hot Stocks
Omnicell to replace Coherent in S&P 400 at open on 7/5 » 04:55
07/05/22
07/05
04:55
07/05/22
04:55
OMCL

Omnicell

$115.30 /

+1.62 (+1.43%)

, COHR

Coherent

$266.26 /

+0.02 (+0.01%)

, IIVI

II-VI

$49.13 /

-1.84 (-3.61%)

II-VI (IIVI) is acquiring…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMCL Omnicell
$115.30 /

+1.62 (+1.43%)

COHR Coherent
$266.26 /

+0.02 (+0.01%)

IIVI II-VI
$49.13 /

-1.84 (-3.61%)

OMCL Omnicell
$115.30 /

+1.62 (+1.43%)

06/16/22 Wells Fargo
Samsung procurement order halt 'positive' for Omnicell, says Wells Fargo
05/03/22 Wells Fargo
Omnicell price target lowered to $158 from $188 at Wells Fargo
05/02/22 Piper Sandler
Omnicell price target lowered to $162 from $181 at Piper Sandler
02/16/22 Wells Fargo
Omnicell price target lowered to $188 from $203 at Wells Fargo
COHR Coherent
$266.26 /

+0.02 (+0.01%)

03/10/22 Benchmark
Coherent, MKS, ASML may be impacted by neon supply from Ukraine, says Benchmark
01/03/22 Raymond James
II-VI upgraded to Outperform from Market Perform at Raymond James
12/13/21 Cowen
II-VI named a best idea for 2022 at Cowen
11/08/21 Northland
NeoPhotonics downgraded to Market Perform from Outperform at Northland
IIVI II-VI
$49.13 /

-1.84 (-3.61%)

07/01/22 Craig-Hallum
II-VI price target lowered to $80 from $85 at Craig-Hallum
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
05/10/22 Raymond James
II-VI price target raised to $82 from $79 at Raymond James
04/14/22 Craig-Hallum
II-VI price target lowered to $85 from $100 at Craig-Hallum
OMCL Omnicell
$115.30 /

+1.62 (+1.43%)

COHR Coherent
$266.26 /

+0.02 (+0.01%)

IIVI II-VI
$49.13 /

-1.84 (-3.61%)

COHR Coherent
$266.26 /

+0.02 (+0.01%)

IIVI II-VI
$49.13 /

-1.84 (-3.61%)

OMCL Omnicell
$115.30 /

+1.62 (+1.43%)

COHR Coherent
$266.26 /

+0.02 (+0.01%)

IIVI II-VI
$49.13 /

-1.84 (-3.61%)

Conference/Events
Sanofi to hold an investor event » 04:55
07/05/22
07/05
04:55
07/05/22
04:55
SNY

Sanofi

$50.91 /

+0.95 (+1.90%)

ESG Investor Event will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$50.91 /

+0.95 (+1.90%)

SNY Sanofi
$50.91 /

+0.95 (+1.90%)

06/07/22 UBS
Sanofi price target raised to EUR 119 from EUR 118 at UBS
06/02/22 Piper Sandler
Regeneron selloff on Libtayo deal overdone, says Piper Sandler
06/01/22 Wells Fargo
Kymera Therapeutics price target lowered to $35 from $62 at Wells Fargo
05/23/22 SVB Leerink
Sanofi initiated with an Outperform at SVB Leerink
SNY Sanofi
$50.91 /

+0.95 (+1.90%)

SNY Sanofi
$50.91 /

+0.95 (+1.90%)

SNY Sanofi
$50.91 /

+0.95 (+1.90%)

Upgrade
Moncler upgraded to Sector Perform from Underperform at RBC Capital » 04:52
07/05/22
07/05
04:52
07/05/22
04:52
MONRF

Moncler

$42.91 /

+ (+0.00%)

RBC Capital analyst Piral…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MONRF Moncler
$42.91 /

+ (+0.00%)

06/28/22 Societe Generale
Moncler price target lowered to EUR 60 from EUR 71 at Societe Generale
06/27/22 UBS
Moncler price target lowered to EUR 59.50 from EUR 62 at UBS
06/27/22 HSBC
Moncler upgraded to Buy from Hold at HSBC
05/06/22 UBS
Moncler price target lowered to EUR 67 from EUR 68.50 at UBS
Initiation
SAP initiated with a Buy at Berenberg » 04:49
07/05/22
07/05
04:49
07/05/22
04:49
SAP

SAP

$90.67 /

-0.08 (-0.09%)

Berenberg analyst Nay Soe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAP SAP
$90.67 /

-0.08 (-0.09%)

SAP SAP
$90.67 /

-0.08 (-0.09%)

07/04/22 Oddo BHF
SAP price target lowered to EUR 93 from EUR 104 at Oddo BHF
07/01/22 Credit Suisse
SAP price target lowered to EUR 121 from EUR 141.22 at Credit Suisse
07/01/22 Credit Suisse
SAP remains top pick in European software at Credit Suisse
06/30/22 Exane BNP Paribas
SAP downgraded to Neutral on near-term risks at BNP Paribas
SAP SAP
$90.67 /

-0.08 (-0.09%)

SAP SAP
$90.67 /

-0.08 (-0.09%)

SAP SAP
$90.67 /

-0.08 (-0.09%)

SAP SAP
$90.67 /

-0.08 (-0.09%)

Upgrade
Remy Cointreau upgraded to Buy from Hold at Jefferies » 04:46
07/05/22
07/05
04:46
07/05/22
04:46
REMYY

Remy Cointreau

$17.55 /

+0.09 (+0.52%)

Jefferies analyst Edward…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REMYY Remy Cointreau
$17.55 /

+0.09 (+0.52%)

06/28/22 Morgan Stanley
Remy Cointreau price target lowered to EUR 150 from EUR 162 at Morgan Stanley
06/07/22 Societe Generale
Remy Cointreau upgraded to Hold from Sell at Societe Generale
05/27/22 Bernstein
Remy Cointreau upgraded to Market Perform from Underperform at Bernstein
05/17/22 Morgan Stanley
Remy Cointreau price target lowered to EUR 162 from EUR 167 at Morgan Stanley
Upgrade
Lonza upgraded to Buy from Neutral at Citi » 04:44
07/05/22
07/05
04:44
07/05/22
04:44
LZAGY

Lonza

$54.66 /

+1.27 (+2.38%)

Citi analyst Vineet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LZAGY Lonza
$54.66 /

+1.27 (+2.38%)

LZAGY Lonza
$54.66 /

+1.27 (+2.38%)

05/20/22 RBC Capital
Lonza upgraded to Outperform from Sector Perform at RBC Capital
04/04/22 Morgan Stanley
Lonza price target lowered to CHF 785 from CHF 800 at Morgan Stanley
02/10/22 Stifel
Lonza upgraded to Buy from Hold at Stifel
01/04/22 JPMorgan
Lonza price target raised to CHF 900 from CHF 850 at JPMorgan
Recommendations
Netflix price target lowered to $210 from $293 at Piper Sandler » 04:40
07/05/22
07/05
04:40
07/05/22
04:40
NFLX

Netflix

$179.70 /

+4.62 (+2.64%)

Piper Sandler analyst…

Piper Sandler analyst Thomas Champion lowered the firm's price target on Netflix to $210 from $293 and keeps an Overweight rating on the shares. "Stranger Things 4" is now the most popular Netflix English-language TV series and second-most popular globally behind "Squid Game," Champion tells investors in a research note. However, the analyst says Netflix's user growth "may remain subdued" as "Top 10" hours in Q4 declined 4% quarter-over-quarter. And with the likely launch of an ad-supported tier, Champion wonders "if management is being more reactive than proactive." While Netflix's valuation is more attractive, it remains above streaming media peers, contends the analyst. He continues to view the company as a "business in transition."

ShowHide Related Items >><<
NFLX Netflix
$179.70 /

+4.62 (+2.64%)

NFLX Netflix
$179.70 /

+4.62 (+2.64%)

06/30/22 Truist
Netflix price target lowered to $210 from $300 at Truist
06/30/22 JPMorgan
Netflix has increased urgency to roll out ads, says JPMorgan
06/29/22 JPMorgan
Netflix price target lowered to $230 from $300 at JPMorgan
06/23/22 BofA
Netflix price target lowered to $196 at BofA after streaming survey
NFLX Netflix
$179.70 /

+4.62 (+2.64%)

NFLX Netflix
$179.70 /

+4.62 (+2.64%)

NFLX Netflix
$179.70 /

+4.62 (+2.64%)

NFLX Netflix
$179.70 /

+4.62 (+2.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.